| abstract |
The present invention provides compounds of the formula (I), wherein the constituent members are defined in the claims, their pharmaceutical compositions and methods for treating excessive sleepiness associated with narcolepsy, obstructive sleep apnea or work change disorder; Parkinson's disease; Alzheimer disease; attention deficit disorder; attention deficit hyperactivity disorder; depression; or fatigue |